AU507515B2 - 9-(p-d-arabindfuranosyl) purine-5'-phosphates - Google Patents

9-(p-d-arabindfuranosyl) purine-5'-phosphates

Info

Publication number
AU507515B2
AU507515B2 AU15004/76A AU1500476A AU507515B2 AU 507515 B2 AU507515 B2 AU 507515B2 AU 15004/76 A AU15004/76 A AU 15004/76A AU 1500476 A AU1500476 A AU 1500476A AU 507515 B2 AU507515 B2 AU 507515B2
Authority
AU
Australia
Prior art keywords
arabindfuranosyl
purine
phosphates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU15004/76A
Other languages
English (en)
Other versions
AU1500476A (en
Inventor
G. B. Rideout J. E. and Miller R. L Elion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU1500476A publication Critical patent/AU1500476A/en
Application granted granted Critical
Publication of AU507515B2 publication Critical patent/AU507515B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Artificial Filaments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU15004/76A 1975-06-17 1976-06-17 9-(p-d-arabindfuranosyl) purine-5'-phosphates Expired AU507515B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB25768/75A GB1562899A (en) 1975-06-17 1975-06-17 Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
GBGB25768/75 1975-06-17

Publications (2)

Publication Number Publication Date
AU1500476A AU1500476A (en) 1977-12-22
AU507515B2 true AU507515B2 (en) 1980-02-21

Family

ID=10232986

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15004/76A Expired AU507515B2 (en) 1975-06-17 1976-06-17 9-(p-d-arabindfuranosyl) purine-5'-phosphates

Country Status (17)

Country Link
US (1) US4136175A (OSRAM)
JP (1) JPS52295A (OSRAM)
AU (1) AU507515B2 (OSRAM)
BE (1) BE843082A (OSRAM)
CA (1) CA1052309A (OSRAM)
CH (1) CH632771A5 (OSRAM)
CS (2) CS191976B2 (OSRAM)
DE (1) DE2627156A1 (OSRAM)
DK (1) DK139727B (OSRAM)
FI (1) FI61315C (OSRAM)
FR (1) FR2361901A1 (OSRAM)
GB (1) GB1562899A (OSRAM)
HU (1) HU176046B (OSRAM)
IL (1) IL49822A (OSRAM)
NL (1) NL7606576A (OSRAM)
SE (1) SE429656B (OSRAM)
ZA (1) ZA763611B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58763B2 (ja) * 1978-07-18 1983-01-07 三井造船株式会社 浮き防氷堤
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
US4315000A (en) 1980-07-07 1982-02-09 Warner-Lambert Company β-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and methods for their production
US4352795A (en) 1981-01-29 1982-10-05 Warner-Lambert Company 7-β-D-Arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine compounds and methods for their production
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US4594415A (en) * 1982-03-29 1986-06-10 Robins Roland K Azole dinucleotide compositions and methods of use
EP0272064B1 (en) * 1986-12-18 1993-03-10 Kyowa Hakko Kogyo Kabushiki Kaisha A process for the preparation of ascorbic acid-2-phosphate
DK0487719T3 (da) * 1990-06-27 1999-05-17 Ash Stevens Inc Fremgangsmåde til fremstilling af 9-beta-D-arabinofuranosyl-2-fluoradenin-5'-phosphat
US5866429A (en) * 1991-04-03 1999-02-02 Bloch; Will Precision and accuracy of anion-exchange separation of nucleic acids
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
EP1337262B1 (en) * 2000-11-08 2008-08-27 FXS Ventures, LLC Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
CA2428985C (en) 2000-11-08 2011-05-24 Bio-Concept Laboratories Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US6624203B1 (en) * 2001-11-08 2003-09-23 Francis X. Smith Nucleic acid bases used in ophthalmic solutions
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328389A (en) * 1964-08-07 1967-06-27 Sankyo Co Process for preparing nucleotide derivatives
US3300478A (en) * 1965-06-01 1967-01-24 Upjohn Co Arabinofuranosyl 2', 5'-and 3'-5'-dinucleoside phosphates and process therefor
US3382232A (en) * 1965-08-26 1968-05-07 Takeda Chemical Industries Ltd Method for the production of 5'-ribonucleotide
US3337530A (en) * 1965-09-20 1967-08-22 Upjohn Co Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
US3448098A (en) * 1966-09-27 1969-06-03 Merck & Co Inc Production of guanylic acid
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
GB1386585A (en) * 1970-11-16 1975-03-12 Wellcome Found Purine sugar derivatives
GB1386584A (en) * 1970-11-16 1975-03-12 Wellcome Found Method of preparation of purine sugar derivatives
IE39184B1 (en) * 1973-03-19 1978-08-16 Icn Pharmaceuticals 9- -d-arabinofuranosyl hypoxanthine nucleotides

Also Published As

Publication number Publication date
DE2627156A1 (de) 1977-01-13
US4136175A (en) 1979-01-23
CA1052309A (en) 1979-04-10
DK139727C (OSRAM) 1979-09-17
CH632771A5 (de) 1982-10-29
FI61315C (fi) 1982-07-12
FR2361901A1 (fr) 1978-03-17
AU1500476A (en) 1977-12-22
BE843082A (fr) 1976-12-17
GB1562899A (en) 1980-03-19
SE429656B (sv) 1983-09-19
JPS52295A (en) 1977-01-05
NL7606576A (nl) 1976-12-21
FR2361901B1 (OSRAM) 1978-12-15
IL49822A (en) 1979-11-30
CS192000B2 (en) 1979-07-31
FI61315B (fi) 1982-03-31
DK139727B (da) 1979-04-02
CS191976B2 (en) 1979-07-31
SE7606913L (sv) 1976-12-18
ZA763611B (en) 1978-01-25
HU176046B (en) 1980-11-28
FI761759A7 (OSRAM) 1976-12-18
DK271876A (OSRAM) 1976-12-18

Similar Documents

Publication Publication Date Title
AU507515B2 (en) 9-(p-d-arabindfuranosyl) purine-5'-phosphates
AU519059B2 (en) Chair
AU504728B2 (en) Amidinoureas
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU498517B2 (en) Thieno-pyridines
AU500738B2 (en) Preparation
AU510088B2 (en) Prostaglandin-acetylene analogues
AU505176B2 (en) Chroman-4-ones
AU497952B2 (en) Polyphosphazene
AU500087B2 (en) Lh-rh analogues
AU503234B2 (en) Plow
AU1128976A (en) Magneto-alternator
AU502349B2 (en) 2-decarboxy-2-amino-prostaglandin analogues
AU511507B2 (en) Funcationalised adenine derivatives
AU501803B2 (en) Fluoro-prostaglandins
CA1027606A (en) Multiduct connector
AU501305B2 (en) N'sulfonyl-n-dihalophenylimidazolidinedioners
SU598015A1 (ru) Дегазатор
AU1492376A (en) Alpha-pyrones
AU494604B2 (en) Antiviral agents
AU501266B2 (en) Easel
AU1562876A (en) Diepoxy-androstanes
AU490730B2 (en) 5(6)-pyridazin-6-yl-benzimidazole derivatives